Home / Journal

The GLP-1 Price Index Journal

In-depth analysis of semaglutide and tirzepatide — what they cost, what the trials actually show, and how to tell verified pricing from marketing. Every post is sourced, dated, and written to the same evidence standard as the rest of the site.

About the Journal

30 articles across pricing and clinical topics, each with comparison tables, a data visualization, an FAQ, and cited sources. Pricing posts are reviewed by Kim Callender, NP; clinical posts by Jonathan Snipes, MD. Educational information, not medical advice.

Pricing & cost analysis (15)

pricing
Brand vs Compounded Semaglutide: Is the Price Gap Worth It?
Brand Wegovy lists near $1,349/month; compounded semaglutide runs $145-299. The gap buys FDA approval, trial evidence, a…
pricing
The Cheapest Legitimate Way to Get Semaglutide in 2026
If insured, a covered Wegovy copay (~$25/mo) is cheapest. Uninsured, compounded semaglutide from ~$145/mo usually beats …
pricing
Compounded Tirzepatide Price by Dose: Does It Rise as You Titrate?
Some compounded tirzepatide programs hold one flat price across all doses; others raise the price as you titrate from 2.…
pricing
GLP-1 Cost Without Insurance: Every Cash-Pay Route Compared
Without insurance, compounded semaglutide ($145-299) is usually cheapest, followed by oral Wegovy (from $149 for qualify…
pricing
GLP-1 Membership Fees: The Hidden Cost That Changes the Ranking
A required $79/month membership turns a $99 medication headline into $178 all-in. Membership fees are the most common wa…
pricing
How the GLP-1 Price Index Works: Reading the Numbers
The GLP-1 Price Index tracks the median effective monthly cost of a defined category, sets a baseline period to 100, and…
pricing
GLP-1 Add-On Fees: Shipping, Labs and Onboarding Compared
Beyond the medication price, GLP-1 programs may charge for shipping, lab work, onboarding, and membership. These add-ons…
pricing
The Most Affordable Compounded Tirzepatide Online in 2026
Compounded tirzepatide runs about $199-297/month across legitimate providers, with MEDVi reporting the lowest published …
pricing
Does Semaglutide Cost More as Your Dose Increases?
It depends on the provider. Many compounded semaglutide programs charge a flat price across all doses; others raise the …
pricing
Semaglutide First-Month vs Renewal Price: The Intro-Rate Trap
Many semaglutide programs advertise a low first-month price ($99) that reverts to a much higher renewal ($299). Compare …
pricing
Semaglutide vs Tirzepatide Cost in 2026: Full Price Breakdown
Compounded semaglutide runs about $145-299/month, compounded tirzepatide $199-297/month. Tirzepatide costs more because …
pricing
The True Annual Cost of Tirzepatide: Commitment Math Explained
A 12-month tirzepatide prepay lowers the monthly rate but locks you in; month-to-month costs more but lets you stop. The…
pricing
Tirzepatide Microdose Programs: Cost and the Evidence Gap
Microdose tirzepatide programs advertise lower monthly prices, but the pricing is often unresolved and the clinical evid…
pricing
The Wegovy Pill vs Injection: Cost and Value Compared
The oral Wegovy tablet (oral semaglutide 25mg) is available from about $149/month for qualifying patients, while injecta…
pricing
Zepbound vs Mounjaro Cost: Same Drug, Different Insurance Math
Zepbound and Mounjaro are both tirzepatide from Eli Lilly. Mounjaro (diabetes) is often covered by insurance including M…

Clinical & scientific evidence (15)

clinical
Compounded GLP-1 Safety: What Evidence Exists and What Doesn't
Compounded GLP-1s are not FDA-approved and have no formulation-specific trial evidence. The active molecules are well-st…
clinical
Beyond Weight Loss: GLP-1 Cardiovascular and Kidney Data
GLP-1 evidence extends beyond weight loss: SELECT showed semaglutide cut cardiovascular events ~20%, and FLOW showed it …
clinical
GLP-1 Contraindications: Who Should Not Take Them
GLP-1 medications are contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN …
clinical
Managing GLP-1 GI Side Effects: What the Evidence Supports
Nausea and other GI effects are the most common GLP-1 side effects, usually mild-to-moderate and worst during dose incre…
clinical
GLP-1 Weight Loss and Muscle: What the Data Shows
A meaningful share of GLP-1 weight loss can be lean mass, not just fat — studies suggest roughly 25-40% of tot…
clinical
GLP-1 Side Effects Compared: Semaglutide vs Tirzepatide
Both semaglutide and tirzepatide most commonly cause gastrointestinal side effects — nausea, diarrhea, vomitin…
clinical
Oral vs Injectable Semaglutide: The Absorption Problem
Oral semaglutide is poorly absorbed through the gut, so it requires a far higher dose (up to 25mg daily for weight manag…
clinical
The SELECT Trial: Semaglutide's 20% Cardiovascular Benefit
The SELECT trial showed semaglutide 2.4mg cut major adverse cardiovascular events by about 20% in adults with overweight…
clinical
How GLP-1 and Dual GIP/GLP-1 Drugs Work in the Body
Semaglutide activates the GLP-1 receptor; tirzepatide activates both GLP-1 and GIP receptors. Both slow gastric emptying…
clinical
Semaglutide Titration: Why Dose Escalation Is Slow
Semaglutide is escalated slowly — typically starting at 0.25mg weekly and increasing every four weeks &mda…
clinical
Weight Regain After Stopping Semaglutide: The Evidence
Trial data (STEP-1 extension, STEP-4) show most people regain a substantial share of lost weight within a year of stoppi…
clinical
STEP-1 Explained: The 14.9% Semaglutide Weight-Loss Result
STEP-1 was the pivotal semaglutide weight-management trial. Over 68 weeks, participants on semaglutide 2.4mg lost about …
clinical
SURMOUNT-5: What the Head-to-Head Trial Actually Showed
SURMOUNT-5 was the first direct trial comparing tirzepatide and semaglutide for weight loss. At 72 weeks, tirzepatide pr…
clinical
Tirzepatide for Sleep Apnea: The SURMOUNT-OSA Evidence
SURMOUNT-OSA showed tirzepatide significantly reduced the severity of obstructive sleep apnea in adults with obesity, le…
clinical
Tirzepatide vs Semaglutide for Type 2 Diabetes
For type 2 diabetes, the SURPASS trials showed tirzepatide produced greater A1c reduction and weight loss than semagluti…